KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 12, 2026 >>  ABB India 6869.1  [ 1.37% ]  ACC 1124.95  [ -0.75% ]  Ambuja Cements 348.85  [ -0.33% ]  Asian Paints 2335  [ -0.43% ]  Axis Bank 1256  [ -0.24% ]  Bajaj Auto 10060  [ 2.79% ]  Bank of Baroda 235  [ -0.42% ]  Bharti Airtel 1778  [ -1.58% ]  Bharat Heavy 439.2  [ 1.48% ]  Bharat Petroleum 285  [ -0.84% ]  Britannia Industries 4780  [ -0.85% ]  Cipla 1313.7  [ 0.80% ]  Coal India 404.4  [ -1.58% ]  Colgate Palm 1770  [ -2.75% ]  Dabur India 376  [ -2.62% ]  DLF 649  [ 0.39% ]  Dr. Reddy's Lab. 1230.5  [ 2.96% ]  GAIL (India) 167.5  [ 0.39% ]  Grasim Industries 2865.5  [ -1.02% ]  HCL Technologies 1220  [ 0.47% ]  HDFC Bank 704.25  [ -0.40% ]  Hero MotoCorp 4926.1  [ 0.35% ]  Hindustan Unilever 1822  [ -2.10% ]  Hindalco Industries 884.7  [ -1.61% ]  ICICI Bank 1345  [ -0.67% ]  Indian Hotels Co. 712  [ -0.46% ]  IndusInd Bank 852.9  [ -1.11% ]  Infosys 1017  [ -0.69% ]  ITC 257.6  [ -3.23% ]  Jindal Steel 1022  [ 0.62% ]  Kotak Mahindra Bank 443  [ 0.66% ]  L&T 3629.9  [ -1.87% ]  Lupin 1946  [ -0.71% ]  Mahi. & Mahi 2815.45  [ 0.84% ]  Maruti Suzuki India 11322.9  [ -0.63% ]  MTNL 24.66  [ 7.59% ]  Nestle India 1321.1  [ -0.90% ]  NIIT 82.52  [ 0.50% ]  NMDC 70.5  [ -2.03% ]  NTPC 310.4  [ -0.23% ]  ONGC 220  [ -0.50% ]  Punj. NationlBak 116  [ -0.68% ]  Power Grid Corpn. 249.25  [ -0.10% ]  Reliance Industries 1159  [ -1.01% ]  SBI 941  [ -1.78% ]  Vedanta 264.75  [ 0.47% ]  Shipping Corpn. 281.3  [ 1.39% ]  Sun Pharmaceutical 1759.1  [ 0.13% ]  Tata Chemicals 637.7  [ 8.12% ]  Tata Consumer 958  [ 0.51% ]  Tata Motors Passenge 284.1  [ 1.79% ]  Tata Steel 172.3  [ -0.75% ]  Tata Power Co. 343.2  [ 0.37% ]  Tata Consult. Serv. 2126.9  [ -1.67% ]  Tech Mahindra 1470  [ -3.10% ]  UltraTech Cement 10554  [ -1.18% ]  United Spirits 1349.5  [ -0.74% ]  Wipro 161.6  [ -0.68% ]  Zee Entertainment 73.99  [ 5.56% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    MOREPEN LABORATORIES LTD.

    12 October 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE083A01026 BSE Code / NSE Code 500288 / MOREPENLAB Book Value (Rs.) 23.78 Face Value 2.00
    Bookclosure 19/09/2026 52Week High 151 EPS 1.73 P/E 73.83
    Market Cap. 7004.49 Cr. 52Week Low 33 P/BV / Div Yield (%) 5.38 / 0.16 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Morepen Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Morepen Laboratories Ltd. 541.04 462.81 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Morepen Laboratories Ltd. 5.31 8.82 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Morepen Laboratories Ltd. 71.62 22.68 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Morepen Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Morepen Laboratories Ltd. 54.00 20.12 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Morepen Laboratories Ltd. 109.58 109.58 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Morepen Laboratories Ltd. 13.23 4.90 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Morepen Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Morepen Laboratories Ltd. 9.98 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Morepen Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Morepen Laboratories Ltd. 1681.20 1554.54 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Morepen Laboratories Ltd. 112.08 153.41 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Morepen Laboratories Ltd. 21.50 15.72 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Morepen Laboratories Ltd. 88.17 137.59 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Morepen Laboratories Ltd. 66.06 101.58 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Morepen Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Morepen Laboratories Ltd. 109.58 109.58 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Morepen Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Morepen Laboratories Ltd. 1133.17 1071.92 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Morepen Laboratories Ltd. 193.59 78.96 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Morepen Laboratories Ltd. 471.31 460.74 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Morepen Laboratories Ltd. 402.63 365.87 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Morepen Laboratories Ltd. 110.04 204.97 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Morepen Laboratories Ltd. 1386.77 1122.02 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Morepen Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Morepen Laboratories Ltd. 6.66 9.86 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Morepen Laboratories Ltd. 3.92 6.53 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Morepen Laboratories Ltd. 1.21 1.85 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Morepen Laboratories Ltd. 5.31 8.59 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Morepen Laboratories Ltd. 0.15 0.06 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Morepen Laboratories Ltd. 8.30 23.81 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Morepen Laboratories Ltd. 2.94 2.44 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Morepen Laboratories Ltd. 0.20 0.20 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Shriram Financial Services Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Shriram Financial Services Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute